Alexion Pharmaceuticals (ENPP1 Deficiency Assets and Intellectual Property) is Buildings and Property in United States that focus on a portfolio business. They cover business area such as a portfolio, patent estate, preclinical datum, manufacturing research, Boston, Massachusetts.
-
A Portfolio
-
121 Seaport Boulevard
Boston, MA 02210
United States
Private
a portfoliopatent estatepreclinical datummanufacturing researchBostonMassachusetts
* We use standard office opening hours in near Alexion Pharmaceuticals (ENPP1 Deficiency Assets and Intellectual Property)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Alexion Pharmaceuticals (ENPP1 Deficiency Assets And Intellectual Property) is Buildings and Property business from United States that founded in - ( years old in ), Alexion Pharmaceuticals (ENPP1 Deficiency Assets and Intellectual Property) business is focusing on A Portfolio.
Alexion Pharmaceuticals (ENPP1 Deficiency Assets and Intellectual Property) headquarter office and corporate office address is located in 121 Seaport Boulevard Boston, MA 02210 United States.
Alexion Pharmaceuticals (ENPP1 Deficiency Assets and Intellectual Property) was founded in United States.
In , Alexion Pharmaceuticals (ENPP1 Deficiency Assets and Intellectual Property) is currently focus on a portfolio sector.
Above is snippet of Google Trends for "a portfolio" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Alexion Pharmaceuticals (ENPP1 Deficiency Assets and Intellectual Property), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
